sc13g1_kiluva1242011.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G/A

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2

(Amendment No. 1)*

Nutraceutical International Corporation

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

67060Y101

(CUSIP Number)

December 13, 2010

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant which this Schedule is filed:

o Rule 13d-1(b)

ý Rule 13d-1(c)

o Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 17 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

This filing is an amendment to the Schedule 13G filed with the Securities and Exchange Commission on February 17, 2009 by the reporting person and certain of its affiliates. This filing indicates the termination of the reporting requirements of Kiluva, S.A. and Felix Revuelta under Rule 13d-1.

CUSIP No. 67060Y101

13G/A

Page 2 of 10



1.	NAMES OF REPORTING PERSONS Kiluva, S.A.
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
	(a) ¨
	(b) þ
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION Spain
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5. SOLE VOTING POWER 0
	6. SHARED VOTING POWER 163,577
	7. SOLE DISPOSITIVE POWER 0
	8. SHARED DISPOSITIVE POWER 163,577
9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 163,577
10.	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)¨
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.5%
12.	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO

CUSIP No. 67060Y101

13G/A

Page 3 of 10



1.	NAMES OF REPORTING PERSONS Felix Revuelta
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
	(a) ¨
	(b) þ
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION Spain
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5. SOLE VOTING POWER 0
	6. SHARED VOTING POWER 163,577
	7. SOLE DISPOSITIVE POWER 0
	8. SHARED DISPOSITIVE POWER 163,577
9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 163,577
10.	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)¨
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.5%
12.	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN

CUSIP No. 67060Y101

13G/A

Page 4 of 10

Item 1(a). Name of Issuer:

The name of the issuer is Nutraceutical International Corporation.

Item 1(b). Address of Issuer’s Principal Executive Offices:

The address of the issuer’s principal executive offices is 1400 Kearns Boulevard, 2nd Floor, Park City, UT 84060.

Item 2(a). Name of Person Filing:

This Schedule 13G/A is filed by Kiluva S.A. (“Kiluva”) and Felix Revuelta.

Item 2(b). Address of Principal Business Office or, if none, Residence:

The address of the principal business office for the reporting persons is Pasaje Pedro Rodriguez, No. 6, 08028 Barcelona (Spain).

Item 2(c). Citizenship:

Kiluva is a corporation domiciled in Spain. Felix Revuelta is a citizen of Spain.

Item 2(d). Title of Class of Securities:

Common Stock, $0.01 par value.

Item 2(e). CUSIP Number:

67060Y101

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)	o	Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
(b)	o	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	o	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	o	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	o	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	o	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	o	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	o	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	o	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
(j)	o	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
(k)	o	Group, in accordance with § 240.13d-1(b)(1)(ii)(J).

If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:________________________________.

Not applicable.

CUSIP No. 67060Y101

13G/A

Page 5 of 10

Item 4. Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a) Amount beneficially owned:

Kiluva beneficially owns directly 0 shares of common stock of the issuer, and beneficially owns indirectly 163,577 shares of common stock of the issuer as a result of its ownership of wholly owned subsidiary Finverki, S.L.U. (“Finverki”), which directly owns 163,577 shares. Felix Revuelta beneficially owns indirectly 163,577 shares of common stock of the issuer as a result of his ownership interest in Kiluva.

(b) Percent of class:

1.5%

(i) Sole power to vote or to direct the vote:

Kiluva does not have sole power to vote or to direct the vote of common stock of the issuer. Felix Revuelta does not have sole power to vote or to direct the vote of common stock of the issuer.

(ii) Shared power to vote or to direct the vote:

Kiluva may be deemed to have shared power to vote or to direct the vote of 163,577 shares of common stock of the issuer held by Kiluva’s wholly owned subsidiary: Finverki (holding 163,577 shares). Felix Revuelta may be deemed to have shared power to vote or to direct the vote of 163,577 shares of common stock of the issuer as a result of his ownership interest in Kiluva.

(iii) Sole power to dispose or to direct the disposition of:

Kiluva does not have sole power to dispose or to direct the disposition of common stock of the issuer. Felix Revuelta does not have sole power to dispose or to direct the disposition of common stock of the issuer.

(iv) Shared power to dispose or to direct the disposition of:

Kiluva may be deemed to have shared power to dispose or to direct the disposition of 163,577 shares of common stock of the issuer held by Kiluva’s wholly owned subsidiary: Finverki (holding 163,577 shares). Felix Revuelta may be deemed to have shared power to dispose or to direct the disposition of 163,577 shares of common stock of the issuer as a result of his ownership interest in Kiluva.

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following. þ

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding

Company or Control Person.

See Exhibit A.

CUSIP No. 67060Y101

13G/A

Page 6 of 10

Item 8. Identification and Classification of Members of the Group.

Not applicable.

Item 9. Notice of Dissolution of Group.

Not applicable.

Item 10. Certifications.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

CUSIP No. 67060Y101

13G/A

Page 7 of 10

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


Dated: January 25, 2011	KILUVA, S.A. /s/ Felix Revuelta
	Felix Revuelta Chairman

	/s/ Felix Revuelta
	Felix Revuelta

CUSIP No. 67060Y101

13G/A

Page 8 of 10

EXHIBIT INDEX

Exhibit A	Identification of subsidiaries which acquired the security being reported on by the parent holding company.

Exhibit B	Joint Filing Agreement.

CUSIP No. 67060Y101

13G/A

Page 9 of 10

EXHIBIT A

IDENTIFICATION OF SUBSIDIARIES WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

Housediet, S.L.U.

Finverki, S.L.U.

Kiluva Diet, S.A.

CUSIP No. 67060Y101

13G/A

Page 10 of 10

EXHIBIT B

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G/A (including amendments thereto) with regard to the common stock of Nutraceutical International Corporation, a Delaware corporation, and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of January 25, 2011.

KILUVA, S.A.

/s/ Felix Revuelta

Felix Revuelta

Chairman

/s/ Felix Revuelta

Felix Revuelta